<DOC>
	<DOCNO>NCT01979692</DOCNO>
	<brief_summary>The hypothesis proposal needle confocal laser microscopy ( nCLM ) may improve yield trans thoracic needle biopsy ( TTNB ) lung mediastinal lesion differentiate viable necrotic tissue . This may reduce number biopsy attempt eventually complication rate procedure .</brief_summary>
	<brief_title>Feasibility Confocal Laser Microscopy ( CLM ) Computed Tomography-guided Needle Biopsy Pulmonary Mediastinal Lesions</brief_title>
	<detailed_description>CT guide needle biopsy ( TTNB - trans thoracic needle biopsy ) pulmonary lesion well establish diagnosis technique pulmonology . It suitable peripheral lung lesion diameter great 2 cm diagnosis mediastinal mass . In situation diagnosis yield may reach 90 % . However small `` non homogenous '' lesion ( CT image ) yield lower 60 % .As usually rapid onsite specimen pathologic examination ( ROSE ) number attempt ( passage ) perform order receive good quality sample . The complication rate TTNB ( pneumothorax bleed ) relatively high ( 15 % 5 % respectively ) . Necrosis common feature rapid grow tumor may significantly impair histopathological diagnosis thus lower TTNB yield . Optimization needle position viable tissue area lesion imperative improve yield TTNB technique . CLM emergent technique low power laser excite autofluorescence induce fluorescence ( intravenous . administration ) tissue . . CLM capable provide examiner near histopathological quality tissue image serve `` optical biopsy '' . The technique well establish dermatology gastroenterology ( via endoscope ) serve distinguish cellular abnormality inflammatory , premalignant malignant disorder . Recently pulmonary application describe allow alveolar real time vision ( alveoscopy ) . While use work channel different endoscope name probe CLE ( probe confocal laser endomicroscopy ) . Needle base confocal laser endomicroscopy ( nCLE ) study diagnostic pancreatic mass celiac/mediastinal lymph node .A probe CLE introduce 19 G needle biopsy endoscopic guidance lesion . Imaging start follow intravenous administration fluorescein .Preliminary result show good quality image also remarkable positive predictive value picture detail normal versus disease tissue . The CLM probe diameter 0,85 mm may introduce 19 G trans thoracic biopsy needle replace stylet . Its field view 320 µm , lateral resolution 3,5 µm , depth 50 µm length 4 m. TTNB perform accord standard protocol Interventional Radiology Department Sheba , follow intravenous administration fluorescein . This protocol describe . After receive consent , patient lie CT table skin chest lesion clean draped usual sterile fashion . Local anesthesia deliver Lidocaine 2 % skin pleura 19G introducer needle advance lesion border CT vision . Via introducer 20G core biopsy needle advance 3-6 biopsy perform . Following procedure another CT scan perform evaluate immediate complication patient transfer recovery room 2 hour observation . Before discharge chest radiography perform evaluate possible pneumothorax bleeding . The use fluorescein pulmonary medicine describe CLM bronchoscope.The protocol consist injection 10 ml 0,25 % sodium fluorescein solution venous catheter immediate rinse 10 ml saline solution 0,9 % . This differ ophthalmologic gastroenterologic protocol use diluted solution . Imaging may start 1 minute follow injection last 10 minute . We expect low side effect fluorescein use describe retinal angiography . Fluorescein stain microvasculature , extracellular matrix cytoplasmic component ( cell nuclei ) epithelium diffuse across capillary extravascular space . CLM fluorescein use diagnose neoplasia present abnormal vessel ( increase size arborization ) . Increased leakage owe neovascularization may also diagnose . On site rapid cytological examination ( ROSE ) standard biopsy quality .</detailed_description>
	<criteria>patient age 18 80 referred TTNB due lung mediastinal lesion . Both gender enrol new diagnosed mediastinal lung mass chest image ( chest radiography compute tomographyCT ) know allergy anesthetic medication , know allergy fluorescein , inability lie CT bed examination cardiovascular instability decide principal investigator.Pregnant woman ' child debilitate patient include</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>CLM</keyword>
	<keyword>The study</keyword>
	<keyword>focus use</keyword>
	<keyword>CLM</keyword>
	<keyword>distinguish</keyword>
	<keyword>viable</keyword>
	<keyword>necrotic tissue</keyword>
	<keyword>TTNB real time</keyword>
</DOC>